Plasminogen activator inhibitor-1 in nonobese subjects with non-insulin-dependent diabetes mellitus

Experimental Biology and Medicine

Volumn 211, Issue 3, 1996, Pages 287-291

  Ito, Yasuko ^a   Okeda, Toshimitsu ^a   Sato, Yasufumi ^a   Ito, Morio ^a   Sakata, Toshiie ^a  

^a OITA UNIVERSITY   (Japan)

Author keywords

[No Author keywords available]

Indexed keywords

C PEPTIDE; CHOLESTEROL; GLUCAGON; GLUCOSE; HEMOGLOBIN A1C; HIGH DENSITY LIPOPROTEIN CHOLESTEROL; INSULIN; LIPID; PLASMINOGEN ACTIVATOR INHIBITOR 1; TRIACYLGLYCEROL;

ADULT; AGED; ARTICLE; BLOOD PRESSURE; CONTROLLED STUDY; FEMALE; GLUCOSE BLOOD LEVEL; HUMAN; INSULIN RELEASE; LEAN BODY WEIGHT; LIPID BLOOD LEVEL; MAJOR CLINICAL STUDY; MALE; NON INSULIN DEPENDENT DIABETES MELLITUS;

ADULT; AGED; DIABETES MELLITUS, TYPE 2; DIABETIC ANGIOPATHIES; FEMALE; HUMANS; INSULIN; MALE; MIDDLE AGED; PLASMINOGEN ACTIVATOR INHIBITOR 1;

EID: 0030004492     PISSN: 00379727     EISSN: None     Source Type: Journal    
DOI: 10.3181/00379727-211-43973     Document Type: Article

References (19)

1. Frade LTG, Calle H, Torrado MC, Lara JI, Cuellar L, Avello AG. Hypofibrinolysis associated with vascuiopathy in non-insulin dependent diabetes mellitus. Thromb Res 59:51-59, 1990.
2. Cho YW, Yang DH, Oh DY, Baick SH, Kim SK, Kim SJ, Hong SY. Plasma tPA and PAI-1 antigen concentrations in non-insulin dependent diabetic patients: Implication for diabetes retinopathy. Diabetes Res Clin Pract 22:123-128, 1994.
3. Walmsley D, Hampton KK, Grant PJ. Contrasting fibrinolytic responses in type 1 (insulin-dependent) and type 2 (non-insulin-dependent) diabetes. Diabetic Med 8:954-959, 1991.
4. Bert-Jan PVL, Leo PH, Cornelius K, Ernest B, Gerard D, Arend EM. Fibrinolytic system during long distance running in IDDM patients and in healthy subjects. Diabetes Care 15:991-996, 1988.
5. Tonny J, Jens BK, Bo Feldt R, Torsten D. Features of endothelial dysfunction in early diabetic nephropathy. Lancet 4:461-463, 1989.
6. Rosaire PG, David LHP, John SY. Plasminogen activator inhibitor activity in diabetic and non-diabetic survivors of myocardial infarction. Arterioscl Thromb 13:415-420, 1993.
7. Johan A, Roger B, Desire C, Jet G. Tissue type plasminogen activator antigen and plasminogen activator inhibitor-1 in diabetes mellitus. Arteriosclerosis 8:68-72, 1988.
8. Vague I, Roul C, Alessi MC, Ardissone JP, Heim M, Vague P. Increased plasminogen activator inhibitor activity in non-insulin dependent diabetic patients: Relationship with plasma insulin. Thromb Haemost 61:370-373, 1989.
9. Mcgill JB, Schneider DJ, Arfken CL, Lucore CL, Sobel BE. Factors responsible for impaired fibrinolysis in obese subjects and NIDDM patients. Diabetes 43:104-109, 1994.
10. Vague P, Juhan VI, Francoise AM. Correlation between blood fibrinolytic activity, plasminogen activator inhibitor level, plasma insulin level and relative body weight in normal and obese subjects. Metabolism 35:250-253, 1986.
11. Vague IJ, Roul C, Alessi MC, Ardissone JP, Heim M, Vague P. Increase of plasma plasminogen activator inhibitor 1 levels. A possible link between insulin resistance and atherosclerosis. Diabetologia 34:457-462, 1991.
12. Madsbad S, Krarup T, McNair P. Practical clinical value of the C-peptide response to glucagon stimulation in the choice of treatment in diabetes meilitus. Acta Med Scand 210:153-157. 1981.
13. Declerck PJ, Alessi MC, Verstreken M, Kruithof EKO, Juhan VI, Collen D. Measurement of plasminogen activator inhibitor 1 (PAI-1) in biological fluids with a murine monoclonal antibody based enzyme-linked immunosorbent assay. Blood 71:220-225, 1988.
14. Friedewald WT, Levy RI, Fredrickson DS. Estimation of the concentration of low density lipoprotein cholesterol in plasma without use of the preparative ultracentrifuge. Clin Chem 18:499-502, 1972.
15. Alessi MC, Juhan VI, Kooistru T, Declerck PJ, Collen D. Insulin stimulates the synthesis of plasminogen activator inhibitor 1 by the human hepatocellular cell line HepG2. Thromb Haemost 60:491-494, 1988.
16. Kooistra T, Bosma P, Tons H, van den Berg A, Meyer P, Princen H. Plasminogen activator inhibitor 1; Biosynthesis and mRNA levels are increased by insulin in cultured human hepatocytes. Thromb Haemost 62:723-728, 1989.
17. Rahm AS, Wiman B, Hamsten A, Nilsson J. Secretion of plasminogen activator inhibitor-1 from cultured human umbilical vein endothelial cells is induced by very low density lipoprotein. Arteriosclerosis 10:1067-1073, 1990.
18. Tremoli E, Camera P, Maderna L, Sironi L, Prati S, Colli F, Piovella F, Bernini F, Corsini A, Mussoni L. Increased synthesis of plasminogen activator inhibitor-1 by cultured human endothelial cells exposed to native and modified LDLs, An LDL receptor-independent phenomenon. Arteriosc Thromb 13:338-346, 1993.
19. Maiello M, Boeri D, Podesta F, Cagliero E, Vichi M, Odetti P, Adezati L, Lorenzi M. Increased expression of tissue plasminogen activator and its inhibitor and reduced fibrinolytic potential of human endothelial cells cultured in elevated glucose. Diabetes 41:1009-1015, 1992.